The cystathionine γ-lyase/hydrogen sulfide pathway mediates the trimetazidine-induced protection of H9c2 cells against hypoxia/reoxygenation-induced apoptosis and oxidative stress
被引:22
|
作者:
Zheng, Wenqing
论文数: 0引用数: 0
h-index: 0
机构:
Weihai Cent Hosp, Dept Cardiovasc Med, Weihai City, Peoples R ChinaWeihai Cent Hosp, Dept Cardiovasc Med, Weihai City, Peoples R China
Zheng, Wenqing
[1
]
Liu, Chao
论文数: 0引用数: 0
h-index: 0
机构:
Shandong Wendeng Osteopath Hosp, Dept Cardiol, Weihai City, Peoples R ChinaWeihai Cent Hosp, Dept Cardiovasc Med, Weihai City, Peoples R China
Liu, Chao
[2
]
机构:
[1] Weihai Cent Hosp, Dept Cardiovasc Med, Weihai City, Peoples R China
[2] Shandong Wendeng Osteopath Hosp, Dept Cardiol, Weihai City, Peoples R China
Objective: Trimetazidine is a piperazine-derived metabolic agent. It exerts cardioprotective effects against myocardial ischemia/reperfusion (I/R) injury. In addition, studies confirm that the cystathionine gamma-lyase (CSE)/hydrogen sulfide (H2S) pathway serves a beneficent role in attenuating myocardial I/R injury. However, the underlying role of the CSE/H2S pathway in the trimetazidine-induced protection against myocardial I/R injury remains elusive. Therefore, this study investigated whether trimetazidine ameliorates hypoxia/reoxygenation (H/R)-induced H9c2 cardiomyocyte injuries in an in vitro cell model of myocardial I/R injury, by enhancing the CSE/H2S pathway. Methods: The H9c2 cell viability was determined with a cell counting Kit-8. Results: Trimetazidine significantly increased the cell viability and decreased lactate dehydrogenase (LDH) release in H/R-treated H9c2 cells. Additionally, trimetazidine increased the H2S levels and the CSE mRNA and protein levels, promoting the CSE/H2S pathway under H/R conditions. The inhibition of the CSE/H2S pathway, induced by transfection with specific siRNA against human CSE (si-CSE), eliminated the trimetazidineinduced upregulation of cell viability, downregulation of LDH release, increase of caspase-3 activity and apoptosis regulator BAX expression, and the decrease of apoptosis regulator Bcl-2 expression, which suggests involvement of the CSE/H2S pathway in trimetazidine-induced cardioprotection. Furthermore, trimetazidine mitigated the H/R-induced increase in reactive oxygen species production and NADPH oxidase 2 expression, and decrease in superoxide dismutase activity and glutathione level, in H9c2 cells. These effects were also reversed by si-CSE. Conclusion: This study revealed that the CSE/H2S pathway mediates the trimetazidine-induced protection of H9c2 cardiomyocytes against H/Rinduced damage by inhibiting apoptosis and oxidative stress.
机构:
Jinan Cent Hosp, Dept Thyroid Surg, Jinan 250013, Peoples R ChinaJinan Cent Hosp, Dept Thyroid Surg, Jinan 250013, Peoples R China
Liu, Hui
Lv, Wei
论文数: 0引用数: 0
h-index: 0
机构:
Jinan Cent Hosp, Dept Cardiovasc Unit2, Jinan 250013, Peoples R ChinaJinan Cent Hosp, Dept Thyroid Surg, Jinan 250013, Peoples R China
Lv, Wei
Ouyang, Li
论文数: 0引用数: 0
h-index: 0
机构:
Outpatient Dept PLA 94201, Dept Surg, Jinan 250013, Peoples R ChinaJinan Cent Hosp, Dept Thyroid Surg, Jinan 250013, Peoples R China
Ouyang, Li
Xu, Li
论文数: 0引用数: 0
h-index: 0
机构:
ShanDong First Med Univ, Cent Hosp, Dept Cardil Intens Care, Jinan 250013, Peoples R ChinaJinan Cent Hosp, Dept Thyroid Surg, Jinan 250013, Peoples R China